In a comparative study of the herbicide oxadiazon, a xenobiotic with peroxisome proliferative activity but structurally distinct from other peroxisome proliferators, in Sprague-Dawley rats, CD1 mice, and Beagle dogs, treatment for fourteen (rats) or twenty-eight (mice and dogs) days produced liver enlargement in all three species (Richert et al
The W/D ratio analysis (Figure 2E) paralleled these findings, showing significant elevation in I/R group compared to control, which was effectively reduced by DEX administration (p = 0.0059 vs
Clinical studies show significant reduction in pigmentation intensity after 12 weeks of consistent use, with some users seeing improvements as early as 4-6 weeks
In SURMOUNT-1, adults on the 15mg dose lost an average of 20.9% of their body weight over 72 weeks
ELISA reagents are optimized for specific batch
Effect of hypoglycemic agents on ischemic preconditioning in patients with type 2 diabetes and symptomatic coronary artery disease